Detalhe da pesquisa
1.
Routine CSF parameters as predictors of disease course in multiple sclerosis: an MSBase cohort study.
J Neurol Neurosurg Psychiatry
; 2024 Apr 03.
Artigo
em Inglês
| MEDLINE | ID: mdl-38569872
2.
The COVID-19 pandemic and neurology: A survey on previous and continued restrictions for clinical practice, curricular training, and health economics.
Eur J Neurol
; 31(3): e16168, 2024 Mar.
Artigo
em Inglês
| MEDLINE | ID: mdl-38038262
3.
The European Academy of Neurology NeuroCOVID-19 Task Force: A lesson for the future.
Eur J Neurol
; : e16321, 2024 Apr 26.
Artigo
em Inglês
| MEDLINE | ID: mdl-38676302
4.
Neurotrophic Factors as Regenerative Therapy for Neurodegenerative Diseases: Current Status, Challenges and Future Perspectives.
Int J Mol Sci
; 24(4)2023 Feb 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-36835277
5.
Autochthonous Cases of Tick-Borne Encephalitis, Belgium, 2020.
Emerg Infect Dis
; 27(8): 2179-2182, 2021 08.
Artigo
em Inglês
| MEDLINE | ID: mdl-34111382
6.
Sativex® (nabiximols) cannabinoid oromucosal spray in patients with resistant multiple sclerosis spasticity: the Belgian experience.
BMC Neurol
; 21(1): 227, 2021 Jun 22.
Artigo
em Inglês
| MEDLINE | ID: mdl-34157999
7.
Made to Measure: Patient-Tailored Treatment of Multiple Sclerosis Using Cell-Based Therapies.
Int J Mol Sci
; 22(14)2021 Jul 14.
Artigo
em Inglês
| MEDLINE | ID: mdl-34299154
8.
Cells to the Rescue: Emerging Cell-Based Treatment Approaches for NMOSD and MOGAD.
Int J Mol Sci
; 22(15)2021 Jul 25.
Artigo
em Inglês
| MEDLINE | ID: mdl-34360690
9.
Long-Term Survival after Progressive Multifocal Leukoencephalopathy in a Patient with Primary Immune Deficiency and NFKB1 Mutation.
J Clin Immunol
; 40(8): 1138-1143, 2020 11.
Artigo
em Inglês
| MEDLINE | ID: mdl-32918165
10.
Clinical and immunological control of experimental autoimmune encephalomyelitis by tolerogenic dendritic cells loaded with MOG-encoding mRNA.
J Neuroinflammation
; 16(1): 167, 2019 Aug 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-31416452
11.
Cognitive-motor interference in persons with multiple sclerosis during five upper limb motor tasks with different complexity.
Mult Scler
; 25(13): 1736-1745, 2019 11.
Artigo
em Inglês
| MEDLINE | ID: mdl-30417718
12.
Fluoxetine in progressive multiple sclerosis: The FLUOX-PMS trial.
Mult Scler
; 25(13): 1728-1735, 2019 11.
Artigo
em Inglês
| MEDLINE | ID: mdl-31218911
13.
Except for C-C chemokine receptor 7 expression, monocyte-derived dendritic cells from patients with multiple sclerosis are functionally comparable to those of healthy controls.
Cytotherapy
; 16(7): 1024-30, 2014 Jul.
Artigo
em Inglês
| MEDLINE | ID: mdl-24856897
14.
Circulating dendritic cells of multiple sclerosis patients are proinflammatory and their frequency is correlated with MS-associated genetic risk factors.
Mult Scler
; 20(5): 548-57, 2014 Apr.
Artigo
em Inglês
| MEDLINE | ID: mdl-24057429
15.
Case report: Psychosis with catatonia in an adult man: a presentation of neurosarcoidosis.
Front Psychiatry
; 15: 1276744, 2024.
Artigo
em Inglês
| MEDLINE | ID: mdl-38501088
16.
A metformin add-on clinical study in multiple sclerosis to evaluate brain remyelination and neurodegeneration (MACSiMiSE-BRAIN): study protocol for a multi-center randomized placebo controlled clinical trial.
Front Immunol
; 15: 1362629, 2024.
Artigo
em Inglês
| MEDLINE | ID: mdl-38680485
17.
Multiple Sclerosis Multidisciplinary Care: A National Survey and Lessons for the Global Community.
Mult Scler Relat Disord
; 85: 105540, 2024 May.
Artigo
em Inglês
| MEDLINE | ID: mdl-38489948
18.
Clinical characteristics and treatment approaches in patients with Susac syndrome: a scoping review of cases.
J Neurol
; 270(12): 5719-5730, 2023 Dec.
Artigo
em Inglês
| MEDLINE | ID: mdl-37668702
19.
Comparative Effectiveness of Autologous Hematopoietic Stem Cell Transplant vs Fingolimod, Natalizumab, and Ocrelizumab in Highly Active Relapsing-Remitting Multiple Sclerosis.
JAMA Neurol
; 80(7): 702-713, 2023 07 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-37437240
20.
Lifestyle factors in multiple sclerosis disability progression and silent brain damage: A cross-sectional study.
Mult Scler Relat Disord
; 65: 104016, 2022 Sep.
Artigo
em Inglês
| MEDLINE | ID: mdl-35809391